Media Summary: Sumaira Ahmed, Founder and Executive Director of The Sumaira Foundation, discusses her organization and the BEST-NMOSD ... David Lewis, MBChB, PhD, FRCPath, Plymouth University, Plymouth, UK, discusses the findings of an analysis of measurable ... David Lewis, MD, Plymouth University, Plymouth, UK, shares results from the ENRICH study (ISRCTN11038174), a randomized ...
New Trial Comparing Rituximab With - Detailed Analysis & Overview
Sumaira Ahmed, Founder and Executive Director of The Sumaira Foundation, discusses her organization and the BEST-NMOSD ... David Lewis, MBChB, PhD, FRCPath, Plymouth University, Plymouth, UK, discusses the findings of an analysis of measurable ... David Lewis, MD, Plymouth University, Plymouth, UK, shares results from the ENRICH study (ISRCTN11038174), a randomized ... Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, Dr. Sharman takes an in-depth look at a clinical Reid Merryman, MD, Dana-Farber Cancer Institute, Boston, MA, presents the preliminary results of a Phase II
Paolo Strati, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses a Phase Ib Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the Phase III ECHO Christian Buske, MD from the University Hospital Ulm, Ulm, Germany discusses the Phase III Barbara Eichhorst, MD, University of Cologne, Cologne, Germany, shares the findings of the seven-year follow-up analysis of the ... This week, Neurology News Network covered the findings of the SPRINT-MIND Andrew Zelenetz, MD, PhD from the Memorial Sloan-Kettering Cancer Center,
